Better Coronavirus Stock: Altimmune vs. Vaxart

Better Coronavirus Stock: Altimmune vs. Vaxart

There are many pharmaceutical companies are pursuing a vaccine, and the market has already started rewarding some of them. For instance, Novavax (NASDAQ: NVAX) is up a startling 2,500% in 2020. Novavax is not the only winner, however.